Statin therapy and plasma C-reactive protein levels in primary prevention

被引：2

作者：

Dzien, A

Dzien-Bischinger, C

Hoppichler, F

Lechleitner, M

机构：

[1] Med Ctr Hentschelhof, Innsbruck, Austria

[2] Hosp Barmherzige Bruder, Salzburg, Austria

[3] Univ Innsbruck, Dept Internal Med, A-6020 Innsbruck, Austria

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 2000年 / 14卷 / 06期

关键词：

statins; plasma CRP;

D O I：

10.1023/A:1007887503287

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：699 / 700

页数：2

共 5 条

[1]

[Anonymous], 1994, CIRCULATION

[2] Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae [J].

Kothe, H ;

Dalhoff, K ;

Rupp, J ;

Müller, A ;

Kreuzer, J ;

Maass, M ;

Katus, HA .

CIRCULATION, 2000, 101 (15) :1760-1763

[3] Long-term effects of pravastatin on plasma concentration of C-reactive protein [J].

Ridker, PM ;

Rifai, N ;

Pfeffer, MA ;

Sacks, F ;

Braunwald, E .

CIRCULATION, 1999, 100 (03) :230-235

[4] Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [J].

Ridker, PM ;

Cushman, M ;

Stampfer, MJ ;

Tracy, RP ;

Hennekens, CH .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :973-979

[5] C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [J].

Ridker, PM ;

Hennekens, CH ;

Buring, JE ;

Rifai, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (12) :836-843

← 1 →